TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Ű¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢support@takara.co.kr
  • ´ëÀüÁö»ç 
  • ¾÷¹«¾È³»¦¢´ëÀü/ÃæÃ»Áö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢042-828-6525
  • Email     ¦¢tkbd@takara.co.kr
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.
Home > ´ÙÄ«¶ó ½ºÆ©µð¿À > ¼îÄÉÀ̽º > ÃÖÀúµ¶¼º, ÃÖ°íÈ¿À²


Àúµ¶¼º °íÈ¿À² Lentivirus transduction, Lenti-X¢â Sponge 2Á¾°ú ÇÔ²²

´ÙÄ«¶óÄÚ¸®¾Æ´Â ´Ù°ø¼º alginate (¾Ë±ä»ê) ±â¹ÝÀÇ sponge ÇüÅÂÀÎ ÃÊÀúµ¶¼º transduction enhancer Á¦Ç°À» Á¦°øÇÕ´Ï´Ù. ¾Ë±ä»êÀº »ýüÀç·á Áß Çϳª·Î ¼¼Æ÷¿¡ ¿µÇâÀ» ¹ÌÄ¡Áö ¾Ê°í °íÈ¿À² Lentivirus transductionÀ» ½ÇÇöÇÒ ¼ö ÀÖ½À´Ï´Ù.
±âÁ¸¿¡ ³Î¸® »ç¿ëµÇ´ø chemical ±â¹Ý enhancerÀÇ ´ÜÁ¡À» ±Øº¹ÇÏ°í ³ôÀº cell viability¸¦ À§ÇØ º°µµÀÇ optimization °úÁ¤ ¾øÀÌ ¼¼Æ÷ handlingÀ» ÁÙÀÎ Á¦Ç°À¸·Î ´õ¿í ºü¸£°í °£ÆíÇÏ°Ô ½ÇÇèÇϼ¼¿ä!
*°ü·Ã Á¦Ç°
- ´Ù¾çÇÑ cell Àû¿ë°¡´ÉÇÑ ³ÐÀº ¹ü¿ë¼º: Lenti-X¢â Transduction Sponge (Code 631478)
: ÀÏ¹Ý cell-line (ºÎÂøÇü, ºÎÀ¯Çü ¼¼Æ÷ ¸ðµÎ °¡´É) ¹× ÇüÁúµµÀÔÀÌ ¾î·Á¿î primary cell »Ó¸¸ ¾Æ´Ï¶ó Ư¼ö ¼¼Æ÷ (eg. ¾Ï¼¼Æ÷) ±îÁö!

- T cell ƯÀÌÀû Ȱ¼ºÈ­·Î T cell ¹× PBMC Àû¿ë °¡´É : Lenti-X¢â T-Cell Transduction Sponge (Code 631480)
: T ¼¼Æ÷ activation ½Ã¾à (rhIL-2, anti-human CD3 & CD28 Ç×ü)ÀÌ Æ÷ÇԵǾî ÀÖ¾î 1 stepÀ¸·Î T cell activation°ú transductionÀ» µ¿½Ã¿¡ ¼öÇà °¡´É!